# Claripi, Inc.

- Location (FDA's records): Seoul, KR
- FDA decisions: 4 (2019–2022): 4 510(k) clearances
- Product codes: LLZ (3), QIH (1)
- 510(k) review time since 2016: median 219 days, against 121 for FDA's reviews in the same codes and years (1 of 4 faster)
- Predicates its devices cite: 4 (1 its own); citations of its devices by later devices: 3 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Zetta Medical Technologies, LLC: 1 (https://510kreport.com/company/zetta-medical-technologies)
- GE Medical Systems: 1 (https://510kreport.com/company/ge-medical-systems)
- Densitas, Inc.: 1 (https://510kreport.com/company/densitas)

## Firms that cite its devices most
- Angiowave Imaging, Inc.: 1 (https://510kreport.com/company/angiowave-imaging)
- Subtle Medical, Inc.: 1 (https://510kreport.com/company/subtle-medical)

## Its most-cited devices
- K212074: ClariCT.AI (2021), cited by 2
- K183460: ClariCT.AI (2019), cited by 1

## Recent decisions
- K203783: ClariPulmo (Apr 6, 2022)
- K203785: ClariSIGMAM (Sep 10, 2021)
- K212074: ClariCT.AI (Jul 27, 2021)
- K183460: ClariCT.AI (Jun 13, 2019)

Source page: https://510kreport.com/company/claripi